Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population

Environmental Health Perspectives

Volumn 116, Issue 4, 2008, Pages 524-531

  Andrew, Angeline S ^a   Jewell, David A ^a   Mason, Rebecca A ^a   Whitfield, Michael L ^a   Moore, Jason H ^a   Karagas, Margaret R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Arsenic; Drinking water; Immune response; Lymphocytes; Microarray; U.S. population

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; DRINKING WATER; GUANINE NUCLEOTIDE BINDING PROTEIN; LECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN; T LYMPHOCYTE RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CELL ACTIVITY; CELL CYCLE REGULATION; CELL GROWTH; CONTROLLED STUDY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; INTERVIEW; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; SAMPLING; SIGNAL TRANSDUCTION; UNITED STATES; WATER CONTAMINATION; WATER SAMPLING;

AGED; ARSENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION; HUMANS; LYMPHOCYTES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UNITED STATES; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 45749137977     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10861     Document Type: Article

References (65)

1. Adrain C, Duriez PJ, Brumatti G, Delivani P, Martin SJ. 2006. The cytotoxic lymphocyte protease, granzyme B, targets the cytoskeleton and perturbs microtubule polymerization dynamics. J Biol Chem 281(12):8118-8125.
2. Andrew AS, Bernardo V, Warnke LA, Davey JC, Hampton T, Mason RA, et al. 2007. Exposure to arsenic at levels found in U.S. drinking water modifies expression in the mouse lung. Toxicol Sci 100:75-87.
3. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, et al. 2006. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 27(5):1030-1037.
4. Andrew AS, Warren AJ, Barchowsky A, Temple KA, Klei L, Soucy NV, et al. 2003. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ Health Perspect 111:825-835.
5. Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, Ahsan H. 2006. Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol Biomarkers Prov 15(7):1367-1375.
6. ATSDR. 2007. Toxicological Profile for Arsenic CAS#: 744G-38-2. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
7. Batta K, Kundu TK. 2007. Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications. Mol Cell Biol 27(21):7603-7614.
8. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, et al. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383(6598): 344-347.
9. Biggs ML, Kalman DA, Moore LE, Hopenhayn-Rich C, Smith MT, Smith AH. 2007. Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat Res 386(3):185-195.
10. + regulatory T cells. J Immunol 178(1):280-290.
11. Cante-Barrett K, Winslow MM, Crabtree GR. 2007. Selective role of NFATc3 in positive selection of thymocytes. J Immunol 179(1):103-110.
12. Chen CJ, Wang SL, Chiou JM, Tsang CH, Chico HY, Hsueh YM, et al. 2007. Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol 222(3): 298-304.
13. Chen CL, Hsu LI, Chiou HY, Hsueh YM, Chen SY, Wu MM, et al. 2004. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA 292(24):2984-2990.
14. Cheng T, Morris J, Koirtyohann S, Spate V, Baskett C. 1995. Study of the correlation of trace elements in carpenter's toenails. J Radioanal Cucl Chem 195:31-42.
15. Conde P, Acosta-Saavedra LC, Goytia-Acevedo RC, Calderon-Aranda ES. 2007. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Arch Toxicol 81(4):251-259.
16. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4(9):R60-R60.
17. Engel RR, Hopenhayn-Rich C, Recevour O, Smith AH. 1994. Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 16(2):184-209.
18. Galicia G, Leyva R, Tenorio EP, Ostrosky-Wegman P, Saavedra R. 2003. Sodium arsenite retards proliferation of PHA-activated T cells by delaying the production and secretion of IL-2. Int Immunopharmacol 3(5):671-682.
19. Gentlemen R, Carey V, Huber W, Irizarry R, Dudoit S, eds. 2005. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York:Springer, 431-442.
20. +/+ mice. Toxicol Sci 95(2):331-339.
21. Gorgoulis VG, Pratsinis H, Zacharatos P, Demoliou C, Sigala F, Asimacopoulos PJ, et al. 2005. p53-Dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Lab Invest 85(4):502-511.
22. Han SG, Castranova V, Vallyathan V. 2005. Heat shock protein 70 as an indicator of early lung injury caused by exposure to arsenic. Mol Cell Biochem 277(1-2):153-164.
23. Hopenhayn C, Bush HM, Bingcang A, Hertz-Picciotto I. 2006. Association between arsenic exposure from drinking water and anemia during pregnancy. J Occup Environ Med 48(6):635-643.
24. IARC (International Agency for Research on Cancer): 2004. Some drinking-water disinfectants and contaminants, including arsenic Monogr Eval Carcinog Risks Hum 84:39-267.
25. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2):249-264.
26. Johnson WE, Li C, Rabinovic A. 2007. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8(1):1118-127.
27. Kamimura T, Shimodaira H, Imoto S, Kim S, Tashiro K, Kuhara S, et al. 2003. Multiscale bootstrap analysis of gene networks based on bayesian networks and nonparametric regression. Genome Inform 14:350-351.
28. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, et al. 2001. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 153(6):559-565.
29. Karagas MR, Stukel TA, Tosteson TD. 2002. Assessment of cancer risk and environmental levels of arsenic in New Hampshire Int J Hyg Environ Health 205(1-2):85-94.
30. Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B. 1998. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 105(suppl 4):1047-1050.
31. Karagas MR, Tosteson TD, Morris JS, Domidenko E, Matt LA, Heaney J, et al. 2004. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15(5):465-472.
32. Kononenko I, Simec E, Robnik-Sikonja M. 1997. Overcoming the myopia of induction learning algorithms with RELIEFF. Appl Intell 7(1):39-55.
33. LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. 2005. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19(6):662-664.
34. Lemarie A, Morzadec C, Bourdonnay E, Fardal O, Vernhet L. 2006. Human macrophages constitute targets for immunotoxic inorganic arsenic. J Immunol 177(5):3019-3027.
35. Lewis TA, Hartmann CB. McCoy KL. 1998. Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages. J Immunol 161(5):2151-2157.
36. Liu J, Kadiiska MB, Liu Y, Lu T, Du W, Waalkes MP. 2001. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci 61(2):314-320.
37. Lu T, Liu J, LeCluyse EL, Zhou YS, Chang ML, Waalkes MP. 2001. Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci 59(1)185-192.
38. Ma K, Chan JK, Zhu G, Wu Z. 2005. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol Cell Biol 25(9):3575-3582.
39. Mead MN. 2005. Arsenic: in search of an antidote to a global poison. Environ Health Perspect 113:A378-A386.
40. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. 2007. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6(4):1-11.
41. Meng Z, Meng N. 1994. Effects of inorganic arsenicals on DNA synthesis in unsensitized human blood lymphocytes in vitro. Biol Trace Elem Res 42(3):201-208.
42. Meza MM. Yu L, Rodriguez YY, Guild M, Thompson D, Gandolfi AJ, et al. 2005. Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children. Environ Health Perspect 113:775-781.
43. Micheli L, Leonardi L, Conti F, Buanne P, Canu N, Caruso M, et al. 2005. PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C. Mol Cell Biol 25(6):2242-2259.
44. Nayak AS, Lage CR, Kim CH. 2007. Effects of low concentrations of arsenic on the innate immune system of the zebrafish (Danio rerio). Toxicol Sci 98(1):118-124.
45. Nery FC, Rui E, Kuniyoshi TM, Kobarg J. 2006. Evidence for the interaction of the regulatory protein Ki-1/57 with p53 and its interacting proteins. Biochem Biophys Res Commun 341(3):847-855.
46. Parham P. 2004. Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. Immunol Lett 92(1-2):11-13.
47. Patterson R. Vega L, Trouba K, Bortner C, Germolec D. 2004. Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice. Toxicol Appl Pharmacol 198(3): 434-443.
48. Rahman A, Vahter M, Ekstrom EC, Rahman M, Golam Mustafa AH, Wahed MA, et al. 2007. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am J Epidemiol 165(12):1389-1396.
49. Ramakrishnan SN, Lau P, Burke LJ, Muscat GE. 2005. Rev-erb-beta regulates the expression of genes involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear receptors and myokines. J Biol Chem 280(10):8651-8659.
50. Reif DM, Dudek SM, Shaffer CM, Wang J, Moore JH. 2005. Exploratory visual analysis of pharmacogenomic results. Pac Symp Biocomput 10:296-307.
51. Reif DM, Moore JH. 2006. Visual analysis of statistical results from microarray studies of human breast cancer. Oncol Rep 15 (spec no.):1043-1047.
52. Rossman TG, Uddin AN, Burns FJ, Bosland MC. 2002. Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies. Environ Health Perspect 110(suppl 5):749-752.
53. Sakurai T, Ohta T, Fujiwara K. 2005. Inorganic arsenite alters macrophage generation from human peripheral blood monocytes. Toxicol Appl Pharmacol 203(2):145-153.
54. Sakurai T, Ohta T, Tomita N, Kojima C, Hariya Y, Mizukami A, et al. 2006. Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages. Int Immunopharmacol 6(2):304-315.
55. Sentman C, Mselle T, Basu S. 2007. Human mucosal NK cells. In: Everything You Always Wanted to Know about NK cells but Were Afraid to Ask (Brossay L, ed). Kerala, India:Transworld Research Network, 99-115.
56. Slotnick MJ, Nriagu JO. 2006. Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ Res 102(1)125-139.
57. Sato-Pena GA, Luna AL, Acosta-Saavedra L, Conde-Moo P. Lopez-Carrillo L, Cebrian ME, et al. 2006. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J 20(6):779-781.
58. Steinmaus C, Yuan Y, Bates MN, Smith AH. 2003. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158(12):1193-1201.
59. Tenorio EP, Saavedra R. 2005. Differential effect of sodium arsenite during the activation of human CD4(+) and CD8(+) T lymphocytes. Int Immunapharmacol 5(13-14):1853-1869.
60. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98(9):5116-5121.
61. Vougelers K, Motyka B, Goping IS, Shostak I, Sawchuk T, Bleackley RC. 2006. Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate. Mol Biol Cell 17(2):623-633.
62. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, et al. 2004. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 112:1329-1333.
63. Wei O, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. 1994. DNA repair and susceptibility to basal cell carcinoma: a case-control study. Am J Epidemiol 140(7):598-607.
64. Wu MM, Chiou HY, Ho IC, Chen CJ, Lee TC. 2003. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ Health Perspect 111:1429-1438.
65. Wu WJ, Tu S, Cerione RA. 2003. Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation. Cell 114(6):715-725.